Related Experiment Video
Updated: May 17, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure
Jeremy Ben-Shoshan1, Michal Entin-Meer, Hanan Guzner-Gur
1Departments of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
Insights
Cardiorenal syndrome (CRS) involves heart and kidney dysfunction, presenting a complex clinical challenge. Understanding its mechanisms and improving treatments are crucial for managing this condition.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiorenal syndrome (CRS) is a complex clinical challenge involving the interplay between heart failure (HF) and renal failure.
- CRS encompasses the worsening of renal insufficiency due to HF and the detrimental effects of kidney dysfunction on the cardiovascular system.
- Recent classification of CRS into subtypes highlights the etiologic and chronologic interactions between cardiac and renal dysfunctions.
Purpose of the Study:
- To review current theories on the mechanistic evolution of cardiorenal syndrome.
- To discuss therapeutic challenges and approaches for managing CRS.
- To emphasize the need for a comprehensive strategy in addressing the dual pathologies of heart and kidney injury.
Main Methods:
- This review synthesizes current scientific literature and clinical understanding of cardiorenal syndrome.
- It examines the multifactorial mechanisms contributing to CRS, including hemodynamic, neurohormonal, and inflammatory components.
- The review analyzes the complexities of managing CRS, considering treatment limitations and the impact on cardiac morbidity.
Main Results:
- CRS mechanisms are multifactorial, involving hemodynamic alterations, neurohormonal activation, and inflammatory processes.
- Managing CRS is challenging, as HF treatments can exacerbate renal dysfunction, a predictor of cardiac morbidity.
- A comprehensive approach is essential for effective clinical investigation and treatment to minimize progression of heart and kidney injury.
Conclusions:
- Further elucidation of CRS mechanisms and treatment strategies is warranted.
- Effective management of CRS requires a holistic approach addressing both cardiac and renal aspects.
- Understanding the intricate relationship between heart and kidney function is crucial for improving patient outcomes in CRS.
Abstract:
Heart failure (HF) accompanied by renal failure, termed cardiorenal syndrome (CRS), encompasses both the development and worsening of renal insufficiency secondary to HF as well as the harmful effects of impaired renal function on the cardiovascular system, and remains a universalclinical challenge. CRS was recently classified into subtypes depending on the etiologic and chronologic interactions between cardiac and renal dysfunctions. The mechanisms underlying the CRS are multifactorial, including hemodynamic alterations, neurohormonal effects, and inflammatory components. However, despite enhanced understanding and awareness of CRS, further elucidation of the mechanisms involved and the appropriate treatment approaches are clearly warranted. CRS is a difficult condition to manage, as treatment to relieve congestive symptoms of HF is limited by a further decline in renal functions, itself a major independent predictor of long-term cardiac morbidity. In order to perform a proper clinical investigation and implement appropriate treatmentthat will minimize subsequent progression of heart and kidney injury, a comprehensive approach to these two pathologies is crucial. In the present review we discuss current theories behind the mechanistic evolution of the CRS as well as therapeutic issues regarding this multifaceted condition.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
